Poster 17

Nemolizumab improves skin lesions, itch and sleep disturbance in patients with moderate-to-severe atopic dermatitis: Results from two identical phase 3 multinational studies (ARCADIA 1 and ARCADIA 2)

Authors: Jonathan I Silverberg, MD; Diamant Thaçi, MD; Kim A Papp, MD; Franz J. Legat, MD; Adam Reich, MD; Andreas Wollenberg, MD, Cheong Soo Yeon; Patricia Fleuranceau Morel; Liliana Ulianov; Christophe Piketty, MD

<PREVIOUS POSTER | NEXT POSTER>

Poster 17